View Author
scopus: 35462222400

Paša-Tolić, L.

(Ljiljana Paša-Tolić)


protein cancer breast tumor proteomic peptide sample breast cancer analysis tissue identification database proteome abundance tamoxifen study profile biomarker approach library erasmus mc patient discovery emmprin therapy number amt tag database proteome res resistance table laser amt tag approach separation expression analyses information isoform response proteome coverage biomarker discovery smith microdissection feature treatment carcinoma lc-ms features technology erasmu membrane intensity addition value differentially level validation tamoxifen therapy resistance splice survival tamoxifen treatment factor spectrometer column cytoplasm gnb 4 protein profile line tamoxifen treatment josephine nefkens institute mass spectrometry microdissected breast carcinoma cells high-throughput subunit 8.6 www.mcponline.org ratio downloaded library month eif 3e masse figure




3 Most Recent Publications

Identification of a putative protein-profile associating with tamoxifen therapy-resistance in breast cancer (Article)
Umar, A. Martens, J.W.M. Foekens, J.A. Paša-Tolić, L. Kang, H. Timmermans, A.M. Look, M.P. Meijer van Gelder, M.E. Jaitly, N. Bakker, M.A. den
2009-06-08
High-throughput proteomics of breast carcinoma cells: a focus on FTICR MS (Article)
Umar, A. Jaremko, M. Burgers, P.C. Luider, T.M. Foekens, J.A. Paša-Tolić, L.
2008-06-05
NanoLC-FTICR MS improves proteome coverage attainable for ~3,000 laser microdissected breast carcinoma cells (Article)
Umar, A. Luider, T.M. Foekens, J.A. Paša-Tolić, L.
2007-01-01